Wellington Management Company »

Perspective Therapeutics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $709k 207k 3.43

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Merck & Co (MRK)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Sempra Energy (SRE)
JPMorgan Chase & Co. (JPM)

View all positions for Wellington Management Company

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Morgan Stanley
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
State Street Corporation
Hills Bank And Trust Company
UBS Group
Walleye Trading Advisors
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Perspective Therapeutics